” … there are known knowns; there are things we know we know. We also know there are known unknowns; that is to say we know there are some things we do not know. ” US Secretary of State Rumsfields as justification for the Iraq war which was a disaster.
Table: pvt = (“Portal vein thrombosis”) (liver) and cvt = (“Cerebral Vein thrombosis”) (brain)
Update 27 April 2021: First up, the number of cerebral (brain) clots are the same for Pfizer and Astra-zeneca vaccines. We will give you the details when they come to hand.
But for now, a Pfizer spokesman claims their rate is less than 2 per million which is less than the background rate. If 2 per milion is background. If 2 per million is background, then so is 4 in a million! The risk from clotting is minimal. Yet it remains the focus of most media and government discussion on vaccines. Why? WBT explores some of the theories below. “But there are also unknown unknowns—the ones we don’t know we don’t know. And if one looks throughout the history of our country and other free countries, it is the latter category that tends to be the difficult ones.” – Donald Rumsfield, former US Secretary of State. But lets not go there.
Why are media and government focusing on Astra-Zeneca vaccine problems and not on Pfizer’s. With the number of COVID deaths on the subcontinent going through the roof … they’re reporting over 2000 deaths per day in India. The scenes there have exposed the weaknesses in the system of government in India. Meanwhile we are asking this question. Looking at the most recent research, which comes out of Oxford University, and is strangely a Department of Psychiatry. The paper called Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine. Curiously, also, the data from the paper comes from the US.
I just want to quote from that paper.
“although the magnitude of the risk cannot be quantified with confidence, the risk after COVID-19 is approximately eight to 10 times that reported for the vaccine. So after you get COVID-19, you’ve got a higher risk by a factor of eight to 10 times of getting a clot, either in your blood or in your portal vein, which is in your liver, and about 100 fold increased risk to the general population rate. The biggest risk for blood clotting is that if you get the COVID-19. Now, of course, the COVID increased rate of CVT, which is the clotting in the brain is notable being much more marked and the increased risk for the other forms of stroke and cerebral hemorrhage. The portal vein data highlight that COVID-19 is associated with thrombotic events (that clotting events), and that are not limited to the cerebral vasculature (not just limited to the brain).
Let’s break down the table shown above for this data. At the current date 20 April 2021, there’s a higher risk (100 times) of blood clots in the brain or liver if you contract COVID-19 while there’s little risk of blood clots from the COVID-19 vaccines, whether they be AstraZeneca, or Pfizer or the many that have been developed in China and India and elsewhere. Pfitzer are saying there are no linked cases of CVTs (brain clots) after 17 million vaccinations.
The Russian vaccine, Sputnik V, has two key advantages that make its distribution easier: it is among the cheapest COVID-19 vaccines and it can be transported easily. At US$10 (£7) a dose – the same as Johnson & Johnson – Sputnik V is only beaten on cost by the Oxford/AstraZeneca vaccine, which comes in at US$4 a dose. This means Sputnik V is more easily accessible for many countries struggling with the cost of vaccinating their population. Like the Oxford/AstraZeneca vaccine, Sputnik V does not require specialised storage. Its liquid version can be stored at household freezer temperatures. A version that can be stored at fridge temperatures is under development and a powder version also exists. It is popular in Latin America but some (US doctors) claim it is a PR exercise by the Russians.
We have noticed that mainstream media in Australia talks a lot about blood clots with the AstraZeneca vaccine, but they do not give the reasons for the clots, or how they form. This is unknown territory, but some possible causes are known. The clots appear to affect younger people more than older people. The reason given by the New Scientist is that the blood clot syndrome involves an unusual type of clot, often one that forms in the brain. And it’s called the cerebral venous sinus thrombosis, or CVST. These are coupled with low levels of platelets whose small particles in the blood stick together to make the clot. So these little platelets are the things that give the body a defence if you’re going to have a bleed; you need those platelets to have the blood clot (but hopefully not in the brain).
Strangely, by some fluke, the Australian Government appears to have done the right thing by trying to get the AstraZeneca vaccine out … there’s been criticisms of how they’ve done that, but nonetheless, they’re trying to get it all out. And we know that the Astra vaccine is more stable than the Pfizer one, because it can be just stored in a normal fridge. The Pfizer vaccine has an unstable mRNA, that’s ribosenucleic acid, which is a genetic material. And, it appears to have less side effects. So AstraZeneca was the one that they chose to roll out initially, and it’s the one that seems to be doing the job.
Please note that 4PR is recommending people go and get the vaccine ASAP, whether it be AstraZeneca or Pfizer, but we would like also to draw attention to some other factors that have come to our attention.
There are claims that drug companies are charging a special pandemic price. I’m sure that they would not be selling at a loss or a small margin. We know that small-margin / high -olume sales have long been an accepted business plan. The share prices of these companies like AstraZeneca, and Pfizer and all the others, Johnson & Johnson, have all been solid, if not spectacular in their increases. Their brand recognition, of course, has skyrocketed in comparison to other big drug companies. That being the case the drug companies are in competition. However drug companies have not always been ethical in prioritising sick people over profit. People are aware of that.
Pfizer may be engaged in, or be part of, a black ops maneuver. Yes, Scotty-from-marketing would know all about back ops. Or Pfizer may quite independently be the beneficiary, because of the way the media is reporting the problems with clotting and relating that mostly to AstraZeneca. If so this amounts to a disinformation campaign against AstraZeneca. From what we can see AstraZeneca vaccine is better overall, it’s more stable, plus it has fewer blood clots.
Even though the Pfizer vaccine laboratory test figures were originally better; the AstraZeneca vaccine is cheaper, and it’s logistically much simpler to distribute. There is a proviso in here, we notice that the cost of the AstraZeneca vaccine in in Britain has been from $3 to $4 for a shot. Whereas in Belgium, it seems to be down around $2. That’s quite a big disparity. So we’re questioning why that is?
It seems that AstraZeneca has been able to enter into licensing agreements, which may also enable it to produce and distribute more easily. Australia’s Commonwealth Serum laboratory is able to adapt its production facility to the Astra vaccine, but not to the Pfizer vaccine. If you look at the data table, Pfizer is only marginally better for the CVT and it’s 27 times worse in relation to the portal vein. A clot in your brain is far more deleterious to your health than a clot in your liver.
The Australian government seem to have been persuaded to reorganize the immunisation regime on the basis that Pfizer is much safer. And this seems to be coming out of reports in the media; the way they’re reporting the problems and the way ministers are talking more about AstraZeneca problems than they are about the Pfizer problems. Taken at its worst, maybe it is ‘black ops’, purely motivated by greed by the big drug companies.
Let’s look at how Astra came to have the Oxford vaccine. AstraZeneca is a Scandinavian company. The Oxford vaccine is headed up by a bit of a vaccine genius who told the UK Government, ‘I could do that’. She apparently had already done that for the Ebola vaccine. Clearly, as an academic department, the academics at Oxford needed to get into bed with a company that could manufacture the vaccines at scale. So they held a beauty parade. The academics wanted to give their creation to humanity, the deal had to be ‘no profiteering for the duration of the pandemic‘, their first choice didn’t want to do that. So AstraZeneca, their second choice, got the deal.
Now let’s have a look at the side effects that I mentioned earlier on in this podcast, you can’t introduce foreign proteins into people and not get adverse side effects.
So the way in which the AstraZeneca vaccine, the way in which the protein that is necessary to immunize you is delivered is through an adeno-virus. It’s a virus from a chimpanzee which doesn’t hurt humans or that’s the theory. It’s carrying a protein which is replicated after being injected into your muscle. And then that’s a signal to the other part of your immune system to wake up and be aware of the COVID-19 virus that may or may not turn up in the body as a result of the pandemic.
It’s is a slightly different story for the Pfizer vaccine – that is in a kind of globule and this mRNA, this small piece of genetic material, which carries the message to the body about being alert to the COVID-19 virus and to get ready to go out all guns blazing, you know, with the antibodies and cells attacking Covid and all that sort of thing.
This globule containing the mRNA goes through the membrane of the cells in the muscle where it’s injected, and it starts replicating the protein – the cell starts to replicate the protein – which is carrying the information for the body to be alert for the COVID-19 and get ready for, you know, all out war, if it should turn up through the lungs or the throat.
The other aspect of it is that this is a massive immunization campaign. Is it the biggest in history? I don’t know, you take the surveillance for side effects very seriously, perhaps the most rigorous capture ever for new agents. So it means that the adverse effects will be noticed! That’s because it’s so huge, the whole immunization campaign. At the moment, here in Australia, they’re rolling out AstraZeneca in Great Britain, they’re rolling out both Pfizer and AstraZeneca. It doesn’t it just depends on what your local GP has is the one that you get, we could make this comparison here to say the Ebola virus in the Democratic Republic of Congo. What say, 100,000 doses were given, so the side effects of less than one and a million would be missed. And so one might doubt that even more common side effects would be would be picked up.
Let’s have a look at the clotting effect. It could be what they call a ‘class effect’. And it might be relevant to all anti COVID vaccines. If the world pooled all the data on the adverse effects broken down by age and sex, maybe the rates of effects wouldn’t differ that much from vaccine to vaccine.
Is Pfizer conducting a black ops disinformation campaign against the Oxford AstraZeneca?
Is the Astra vaccine better overall? It’s cheaper. It’s logistically simpler to distribute. And yes, Pfizer’s efficacy is probably a bit better than AstraZeneca. So how do I decide which one is better? It’s not easy as it is still early days. And it looks like the clotting complications are worse, in the below 60s, and maybe worse either with AstraZeneca or Pfizer. There are some unreported complications with the Pfizer vaccine like swelling of the face.
It may just be a sound precautionary principle, to recommend that the under 60s have another vaccine where an alternative is available. And so it doesn’t have to be a conspiracy
On the evidence currently available, we’re not really saying that there is a black ops conspiracy. We may know pretty soon when research papers like the Cerebral venous thrombosis one get peer reviewed.
The United Kingdom’s drug Regulation Authorityt(he MHRA) has been tardy in reporting the clotting problems and you have to wonder why? Hopefully, the unhealthy nexus between the UK Government and AstraZeneca wasn’t a factor. But if the MHRA had actively decided to delay the release, drug regulation authorities elsewhere, especially in the honest Scandanavia would be releasing them anyway. Hee, hee. If a substantial differences in complication rates emerged, it would smell very fishy. So there you have it. I hope it comes across as not being entirely mad, but that’s the latest we’ve got from 4PR – Voice of the People.
22 April 2021
Consent form for COVID-19 vaccination
About COVID-19 vaccination
People who have a COVID-19 vaccination have a much lower chance of getting sick from the disease called COVID-19.
The COVID-19 vaccination is free. You choose whether to have the vaccination or not.
To be vaccinated you will get a needle in your arm. You need to have the vaccination two times on different days. There are different brands of vaccine. You need to have the same brand of vaccine both times. The person giving you your vaccination will tell you when you need to have the second vaccination.
Medical experts have studied COVID-19 vaccines to make sure they are safe. Most side effects are mild and don’t last for long. As with any vaccine or medicine, there may be rare and/or unknown side effects.
You can tell your healthcare provider if you have any side effects like a sore arm , headache , fever or any other side effect you are worried about. You may be contacted by SMS within the week after receiving the vaccine to see how you are feeling after vaccination.
Some people may still get COVID-19 after vaccination. So you must still follow public health precautions as required in your state or territory to stop the spread of COVID-19 including:
• keep your distance – stay at least 1.5 metres away from other people
• washing your hands often with soap and water, or use hand sanitiser
• wear a mask, if your state or territory has advised that you should
• stay home if you are unwell with cold or flu-like symptoms and
arrange to get a COVID-19 test. Vaccination providers record all vaccinations on the Australian Immunisation Register, as required by Australian law. You can view your vaccination record online through your.* Medicare account * MyGov Account or * My Health Record Account How is the information you provide at your appointment used
On the day you receive your vaccine Before you get vaccinated, tell the person giving you the vaccination if you:• Have any allergies, particularly anaphylaxis (a severe allergic reaction) to a previous dose of a COVID-19 vaccine, to an ingredient of a COVID -19 vaccine or to other vaccines or medications. An allergy is when you come near or in contact with something and your body reacts to it and you get sick very quickly. This may include
things like an itchy rash, your tongue getting bigger, your breathing getting faster, you wheeze or your heart beating faster.
• If you are immuno-compromised. This means that you have a weakened immune system that may make it harder for you to fight infections and other diseases. Sometimes a disease like diabetes or cancer can cause this or certain medicines or treatments you take, such as medicine for cancer.
Questions you will be required to answer
Do you have any serious allergies, particularly anaphylaxis, to anything? Have you had an allergic reaction after being vaccinated before?
Do you have a mast cell disorder?
Have you had COVID-19 before?
Do you have a bleeding disorder?
Do you take any medicine to thin your blood (an anticoagulant therapy)?
Do you have a weakened immune system (immunocompromised)?
Are you pregnant or do you think you might be pregnant? D Are you breastfeeding?
Have you been sick with a cough, sore throat, fever or are feeling sick in D another way?
Have you had a COVID-19 vaccination before?
Have you received any other vaccination in the last 14 days?•If you have any questions or concerns before getting your COVID?
Please talk to your doctor before vaccination.
19 April 2021
Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine @ https://osf.io/a9jdq/